Bionano Genomics (BNGO) Price to Sales (2018 - 2026)

Bionano Genomics has disclosed Price to Sales across 9 years of filings, most recently posting 1.63 for Q2 2026.

• In Q2 2026, Price to Sales fell 14.48% year-over-year to 1.63; the TTM figure through Jun 2026 stood at 0.44 (down 5.67% YoY), while the FY2025 annual figure was 0.29, down 59.33% from the prior year.
• Price to Sales came in at 1.63 for Q2 2026 at Bionano Genomics, down from 1.97 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 7872.84 in Q1 2022 to a low of 1.05 in Q4 2025.
• Average Price to Sales over 5 years is 1421.21, with a median of 382.46 recorded in 2024.
• Year-over-year, Price to Sales sank 99.69% in 2025 and surged 47.23% in 2026.
• Over 5 years, Price to Sales stood at 3168.99 in 2022, then plunged by 88.6% to 361.22 in 2023, then slumped by 99.25% to 2.71 in 2024, then plunged by 61.33% to 1.05 in 2025, then soared by 55.45% to 1.63 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 1.63 in Q2 2026, 1.97 in Q1 2026, and 1.05 in Q4 2025.